JP6574839B2 - 疎水性ハプテン被検体の正確なアッセイ測定 - Google Patents

疎水性ハプテン被検体の正確なアッセイ測定 Download PDF

Info

Publication number
JP6574839B2
JP6574839B2 JP2017532940A JP2017532940A JP6574839B2 JP 6574839 B2 JP6574839 B2 JP 6574839B2 JP 2017532940 A JP2017532940 A JP 2017532940A JP 2017532940 A JP2017532940 A JP 2017532940A JP 6574839 B2 JP6574839 B2 JP 6574839B2
Authority
JP
Japan
Prior art keywords
analyte
vitamin
concentration
sample
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2017532940A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018501485A (ja
JP2018501485A5 (enExample
Inventor
バハール、アイザック
チュエン ウエイ、ティエ
チュエン ウエイ、ティエ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Publication of JP2018501485A publication Critical patent/JP2018501485A/ja
Publication of JP2018501485A5 publication Critical patent/JP2018501485A5/ja
Application granted granted Critical
Publication of JP6574839B2 publication Critical patent/JP6574839B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C10/00Computational theoretical chemistry, i.e. ICT specially adapted for theoretical aspects of quantum chemistry, molecular mechanics, molecular dynamics or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Computing Systems (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
JP2017532940A 2014-12-17 2015-12-11 疎水性ハプテン被検体の正確なアッセイ測定 Expired - Fee Related JP6574839B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462093105P 2014-12-17 2014-12-17
US62/093,105 2014-12-17
PCT/US2015/065253 WO2016100117A2 (en) 2014-12-17 2015-12-11 Accurate assay measurement of hydrophobic haptenic analytes

Publications (3)

Publication Number Publication Date
JP2018501485A JP2018501485A (ja) 2018-01-18
JP2018501485A5 JP2018501485A5 (enExample) 2019-01-17
JP6574839B2 true JP6574839B2 (ja) 2019-09-11

Family

ID=56127821

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017532940A Expired - Fee Related JP6574839B2 (ja) 2014-12-17 2015-12-11 疎水性ハプテン被検体の正確なアッセイ測定

Country Status (6)

Country Link
US (1) US10191069B2 (enExample)
EP (1) EP3234104B1 (enExample)
JP (1) JP6574839B2 (enExample)
CN (1) CN107002017B (enExample)
ES (1) ES2698518T3 (enExample)
WO (1) WO2016100117A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106199015B (zh) * 2016-06-27 2018-08-17 江苏拜明生物技术有限公司 用于血清样品检测的维生素d释放剂、制备方法及应用
CN108982882A (zh) * 2018-06-22 2018-12-11 卢氏实验室公司 一种数字化信息化维生素d快速检测系统和方法
JP7044948B1 (ja) 2019-03-19 2022-03-30 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド 疎水性分析物のin vitro診断アッセイにおけるリポタンパク質妨害を軽減する組成物、デバイス、および方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005049223A (ja) * 2003-07-29 2005-02-24 Toto Ltd 生体情報測定装置および便器
US8185318B2 (en) * 2006-01-19 2012-05-22 Novx Systems Canada Inc. Method of compensation of dose-response curve of an assay for sensitivity to perturbing variables
DK2126586T3 (da) * 2007-02-01 2010-10-11 Immundiagnostik Ag Direkte bestemmelse af vitamin D i serum eller plasma
CN102812356B (zh) * 2009-12-11 2017-08-08 奎斯特诊断投资公司 多重样品中的甾族化合物的质谱法
US20130084592A1 (en) * 2011-10-04 2013-04-04 Siemens Healthcare Diagnostics Inc. Methods for correcting assay measurements
US9244036B2 (en) 2012-11-16 2016-01-26 Cilag Gmbh International System and method for determination of a concentration of at least one interfering substance and correction of glucose concentration based on the concentration of the interfering substance
US9618523B2 (en) * 2013-02-28 2017-04-11 Siemens Healthcare Diagnostics Inc. Methods and reagents for determining isomeric analytes
BR112016030560A8 (pt) 2014-06-27 2021-07-13 Siemens Healthcare Diagnostics Inc parceiros de ligação específicos para epímeros de vitamina d, anticorpo e método para separar uma vitamina d epimérica de uma amostra suspeita de conter uma vitamina d epimérica
EP3177297B1 (en) 2014-06-27 2021-04-07 Siemens Healthcare Diagnostics Inc. Compositions relating to vitamin d
US9804176B2 (en) 2014-06-27 2017-10-31 Siemens Healthcare Diagnostics Inc. Assays for vitamin D epimers

Also Published As

Publication number Publication date
EP3234104A2 (en) 2017-10-25
EP3234104B1 (en) 2018-08-22
EP3234104A4 (en) 2017-10-25
WO2016100117A2 (en) 2016-06-23
JP2018501485A (ja) 2018-01-18
CN107002017B (zh) 2020-07-28
US20170356922A1 (en) 2017-12-14
WO2016100117A3 (en) 2016-08-18
US10191069B2 (en) 2019-01-29
ES2698518T3 (es) 2019-02-05
CN107002017A (zh) 2017-08-01

Similar Documents

Publication Publication Date Title
Hollis The determination of circulating 25-hydroxyvitamin D: no easy task
US4604365A (en) Immunoprecipitation assay
US5705353A (en) Method of reducing interferences in assays
Dinis-Oliveira Heterogeneous and homogeneous immunoassays for drug analysis
JP2021119355A (ja) ビタミンdをアッセイするための方法および組成物
US10338084B2 (en) Processing reagent and use thereof in assays for detection of analytes associated with a binding protein
EP3318878A2 (en) Prostate antigen standards and uses thereof
CN105548585A (zh) 通过差分带电荷微粒迁移率进行脂蛋白分析
CN101201354B (zh) 甲状腺素化学发光免疫分析定量测定试剂盒及制备方法
US20130084592A1 (en) Methods for correcting assay measurements
JP6574839B2 (ja) 疎水性ハプテン被検体の正確なアッセイ測定
JP6388861B2 (ja) 検体総濃度の特定
Yuan et al. Application of a micro plasma collection card for the detection of homocysteine by liquid chromatography with tandem mass spectrometry
JPH1183855A (ja) 改良された蛍光偏光免疫測定法
CN102967713A (zh) 同型半胱氨酸检测试剂盒及其制备方法
Huang et al. Establishment and validation of a time-resolved fluoroimmunoassay for chlorpromazine
CN110346575A (zh) 一种同型半胱氨酸荧光免疫层析检测试剂盒及其检测方法
Kushioka et al. Analysis of vitamin D metabolites in biological samples using a nanoluc-based vitamin D receptor ligand sensing system: NLucVDR
EP0079962B1 (en) Immunoprecipitation assay
EP3770606A1 (en) Method for judging psychiatric disorder
Owen Measurement of glucocorticoids in biological fluids
Gao et al. Simultaneous quantification of four urinary biomarkers related to oxidative stress using UHPLC-QqQ-MS/MS
Ogus et al. HOW SUCCESSFUL ARE LABORATORY TEST COMBINATIONS? A PRELIMINARY STUDY WITH DISCRIMINANT ANALYSIS.
CN106990057A (zh) 一种检测5‑羟吲哚乙酸试剂及制备方法
CA1192490A (en) Immunoprecipitation assay

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181130

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20181130

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20190225

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190513

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190723

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190819

R150 Certificate of patent or registration of utility model

Ref document number: 6574839

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees